Valganciclovir 50268-0787-12
- Manufacturer
- Avpak
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 27, 2016
- Listing Expires
- December 31, 2026
- Application
- ANDA205166
Need to source Valganciclovir? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Valganciclovir Hydrochloride | 450 mg/1 |
Drug Class
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]DNA Polymerase Inhibitors [MoA]Nucleoside Analog Antiviral [EPC]
Selected Package
50268-0787-12Selected20 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-787-12) / 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-787-11)